Journal
EMBO MOLECULAR MEDICINE
Volume 9, Issue 1, Pages 78-95Publisher
WILEY-BLACKWELL
DOI: 10.15252/emmm.201606345
Keywords
blood pressure; COX; glutathione; mitochondrial disease; SQR
Categories
Funding
- Ministerio de Economia y Competitividad, Spain
- ERDF [SAF2013-47761-R, SAF2014-55523-R, RD12/0042/0011, SAF2015-65786-R]
- Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [P10-CTS-6133]
- NIH [P01HD080642]
- foundation todos somos raros, todos somos unicos
- Ramon y Cajal National Programme, Ministerio de Economia y Competitividad, Spain [RYC-2011-07643]
Ask authors/readers for more resources
Coenzyme Q (CoQ) is a key component of the mitochondrial respiratory chain, but it also has several other functions in the cellular metabolism. One of them is to function as an electron carrier in the reaction catalyzed by sulfide:quinone oxidoreductase (SQR), which catalyzes the first reaction in the hydrogen sulfide oxidation pathway. Therefore, SQR may be affected by CoQ deficiency. Using human skin fibroblasts and two mouse models with primary CoQ deficiency, we demonstrate that severe CoQ deficiency causes a reduction in SQR levels and activity, which leads to an alteration of mitochondrial sulfide metabolism. In cerebrum of Coq9(R239X) mice, the deficit in SQR induces an increase in thiosulfate sulfurtransferase and sulfite oxidase, as well as modifications in the levels of thiols. As a result, biosynthetic pathways of glutamate, serotonin, and catecholamines were altered in the cerebrum, and the blood pressure was reduced. Therefore, this study reveals the reduction in SQR activity as one of the pathomechanisms associated with CoQ deficiency syndrome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available